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Culturing cells and tissues in vitro has provided valuable insights into the molecular mechanisms regulating 
redox signaling in cells with implications for medicine. However, standard culture techniques maintain 
mammalian cells in vitro under an artiﬁcial physicochemical environment such as ambient air and 5% 
CO 2 . Oxidative stress is caused by the rapid oxidation of cysteine to cystine in culture media catalyzed by
transition metals, leading to diminished intracellular cysteine and glutathione (GSH) pools. Some cells, such 
as ﬁbroblasts and macrophages, express cystine transport activity, designated as system x c − , which enables 
cells to maintain these pools to counteract oxidative stress. Additionally, many cells have the ability to activate 
the redox sensitive transcription factor Nrf2, a master regulator of cellular defenses against oxidative stress, 
and to upregulate xCT, the subunit of the x c − transport system leading to increases in cellular GSH. In contrast,
some cells, including lymphoid cells, embryonic stem cells and iPS cells, express relatively low levels of xCT 
and cannot maintain cellular cysteine and GSH pools. Thus, ﬁbroblasts have been used as feeder cells for the
latter cell types based on their ability to supply cysteine. Other key Nrf2 regulated gene products include 
heme oxygenase 1, peroxiredoxin 1 and sequestosome1. In macrophages, oxidized LDL activates Nrf2 and 
upregulates the scavenger receptor CD36 forming a positive feedback loop to facilitate removal of the oxidant 
from the vascular microenvironment. This review describes cell type speciﬁc responses to oxygen derived 
stress, and the key roles that activation of Nrf2 and membrane transport of cystine and cysteine play in the
maintenance and proliferation of mammalian cells in culture. 
c © 2014 The Authors. Published by Elsevier B.V. 
This is an open access article under the CC BY-NC-ND license 
( http: // creativecommons.org / licenses / by-nc-nd / 3.0 / ). ntroduction 
Culturing mammalian cells in vitro is a basic technology support- 
ng modern biology and clinical applications. However, freshly iso- 
ated cells from mammalian tissues are exposed to artiﬁcial physic- 
chemical environments, quite different from those encountered in 
ivo, and only cells with the ability to adapt to such conditions can 
urvive and proliferate. Abbreviations: BCS, bathocuproine sulfonate; ES cells, embryonic stem cells; HO- 
, heme oxygenase 1; Prx1, peroxiredoxin 1; SQSTM1, sequestosome1; 4HNE, 4- 
ydroxynonenal; iPS cells, induced pluripotent stem cells; Keap1, Kelch-like ECH- 
ssociated protein 1; Nrf2, nuclear factor erythroid 2-related factor 2; MRPs, multidrug 
esistance-associated proteins; oxLDL, oxidized low density lipoprotein. 
* Corresponding author: 
E-mail address: ishiitetsuro305@gmail.com (T. Ishii). 
213-2317/ $ - see front matter c © 2014 The Authors. Published by Elsevier B.V. This is an
icenses / by-nc-nd / 3.0 / ). 
ttp://dx.doi.org/10.1016/j.redox.2014.04.008 In the 1970s, feeder layer cells or small thiol compounds were in- 
troduced to support survival, proliferation and differentiation of vari- 
ous cell types unable to adapt to culture media ( Table 1 ). Unlike ﬁbrob- 
lasts, non-adherent mouse spleen lymphocytes exhibit limited viabil- 
ity during culture in conventional media [ 1 ]. Chen and Hirsch were the 
ﬁrst to demonstrate that co-culture with peritoneal macrophages en- 
hanced the viability and antibody production by spleen lymphocytes 
[ 1 ]. Moreover, replacement of macrophages by supplementation of 
2-mercaptoethanol (2ME, 10–100 μM) to culture media restored the 
viability and antibody forming capacity of lymphocytes [ 1 ]. Thymus 
feeder cell layers have also been used to sustain proliferation and 
differentiation of T lymphocytes [ 2 ], while human skin ﬁbroblasts 
and epithelial cells can serve as feeder cells for human malignant 
lymphoma cell lines [ 3 ]. Broome and Jeng reported that low concen- 
trations of selected thiol compounds, such as α-thioglycerol and 2ME, 
promote growth of mouse lymphoma L1210 cells in vitro [ 4 ]. Oshima 
established that feeder layer dependent embryonic carcinoma cells  open access article under the CC BY-NC-ND license ( http: // creativecommons.org / 
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 can proliferate in the absence of feeder cells when 2ME is supple-
mented [ 5 ]. Similarly, ﬁbroblasts feeder cells can enhance prolifera-
tion of pluripotent hemopoietic stem cells in culture [ 6 ]. These studies
establish the validity of using feeder cells or 2ME in the maintenance
of various lymphoid and stem cells, although the mechanisms by
which feeder cells and / or 2ME sustained cell viability were unknown
at that time. Recent reviews [ 7 –11 ] describe the application of these
methods for the culture of human embryonic stem (hES) cells and
induced pluripotent stem (iPS) cells (see Table 1 ). 
An important environmental stress in culture medium is oxygen
dependent transition metal-catalyzed rapid oxidation of cysteine to
cystine, resulting in depletion of intracellular cysteine and glutathione
(GSH) pools critical for protein synthesis and detoxiﬁcation, respec-
tively [ 12 , 13 ]. In the 1980s, pioneering research led by Shiro Bannai
established the importance of membrane cystine transport activity
in maintaining intracellular cysteine and GSH pools to counteract ox-
idative stress [ 14 , 15 ]. Many cells, such as ﬁbroblasts, macrophages,
hepatocytes and vascular smooth muscle cells, express cystine trans-
port activity and thus can survive and proliferate in deﬁned culture
media. Such cells are able to change air-oxidized media to reduced
media by generating cysteine and protein thiols as a result of cystine
uptake and diffusion of cysteine from cells [ 16 ]. 
However, some cells including mouse lymphocytes and lymphoid
cells lack cystine transport activity and depend exclusively on supply
of extracellular cysteine for their survival and proliferation [ 17 –19 ].
These cells cannot adapt to conventional culture conditions using in-
cubators gassed with ambient oxygen and 5% CO 2 . However, there are
some culture methods to surmount this difﬁculty. One of the widely
used methods is to co-culture with feeder cells, which express cys-
tine transport activity and are thus able to change an oxidized culture
media to a reduced one, thereby providing cysteine for the cells deﬁ-
cient in cystine transport activity. We here review the development
of methods used for supporting the survival and proliferation of cells
deﬁcient in cystine transport activity. 
After the discovery of the cystine / glutamate speciﬁc anionic
amino acid transporter designated system x c − , further research estab-
lished the importance of the transcription factor nuclear factor ery-
throid 2-related factor 2 (Nrf2) as a regulator of the cystine transporter
(xCT, a component of system x c − ) and stress-induced antioxidant
proteins involved in the protection of cells against oxidative stress
[ 20 , 21 ]. As an example, we describe here the major Nrf2-regulated
gene products expressed in activated macrophages and their involve-
ment in protection against oxidative stress. Macrophages play im-
portant roles in effectively removing oxidized low density lipopro-
teins (oxLDL) and lipid oxidative products such as 4-hydroxynonenal
(4HNE) following the activation of Nrf2. 
Importance of cystine transport in the regulation of cellular 
redox balance 
The disulﬁde amino acid cystine is one of the essential amino
acids in deﬁned culture media used for many mammalian cell types
including human diploid ﬁbroblasts. Bannai et al. found that cystine
deﬁciency in culture media speciﬁcally causes rapid cell death due
to depletion of cellular GSH [ 12 ]. He subsequently characterized a
novel membrane transport activity mediating exchange of extracel-
lular cystine and intracellular glutamate, and designated this amino
acid transporter as system x c − [ 14 , 15 , 22 , 23 ] ( Fig. 1 ). This transport
system plays a key role in regulating cystine uptake, leading to main-
tenance of intracellular cysteine and GSH pools [ 15 , 22 ]. 
Amino acid membrane transport is mediated by transporters rec-
ognizing both chemical structure and ionic charge of amino acids
[ 24 –26 ]. They are classiﬁed into acidic, neutral and basic amino acid
transporters depending on their net charge. The transport of neu-
tral amino acids with short, polar, or linear side chains is mediated
by Na + -dependent, highly concentrative system A and ASC, whereasbranched chain and aromatic amino acids are mainly transported by a
Na + -independent system L [ 24 –27 ]. Notably, cysteine is mainly taken
up by cells via system A and ASC, and efﬂuxes from cells through sys-
tem L [ 24 –27 ]. The cystine / glutamate transport system x c − is a Na 
+ -
independent exchange transporter preferring the acidic / anionic form
of cystine and glutamate having a net negative charge [ 23 ]. Due to a
high intracellular glutamate content and presence of cystine only in
the medium, system x c − catalyzes export of one glutamate and im-
port of one cystine in an exchange reaction ( Fig.1 ) [ 15 , 23 ]. Cystine
is readily reduced to cysteine in cells. Extracellular glutamate and
homocysteate competitively inhibit import of cystine [ 14 ]. Many of
the amino acid transporters have been cloned [ 25 , 26 ] and system x c −
is comprised of two components xCT and 4F2hc linked by disulﬁde
[ 25 , 28 ]. The former component is stress-inducible and the latter is
constitutively expressed [ 28 ]. Notably, the heavy subunit 4F2hc as-
sociates with other amino acid exchanger systems such as system L,
y + L and asc [ 25 ]. 
The rate-limiting step for GSH synthesis is the pool size of cellular
cysteine in cultured cells, as it is relatively small compared to those of
glycine and glutamate. Cystine transport activity and cysteine efﬂux
from cells determines the size of the cellular cysteine pool. Notably,
the reduced form of GSH can also efﬂux from cells via transporters
such as multidrug resistance proteins (MRPs) and is rapidly degraded
to dipeptides and amino acids at the extracellular surface [ 29 ]. The
oxidation of cysteine is catalyzed by heavy metals such as Cu + [1] in
the presence of oxygen [ 13 ]. Most culture media contain a 5–20-fold
greater concentration of glutamine to support cell growth. Glutamine
is taken up via system A and ASC [ 25 , 26 ] and metabolized to gluta-
mate by cellular glutaminase, and hence the cellular glutamate pool
depends largely on levels of extracellular glutamine [ 30 ]. The high
intracellular glutamate thus formed is used for uptake of cystine via
the exchange transport system x c − [ 23 ]. It has been estimated that
one-third to one-half of the total consumption of glutamine is used
for the uptake of cystine during culture of human diploid ﬁbroblasts
[ 30 ]. 
Culture media are usually air-oxidized during storage. Cysteine,
if added, is oxidized to cystine over short time periods and reactive
cysteine residues in serum albumin are masked mainly by cysteine
through disulﬁde formation. When pre-conﬂuent human diploid ﬁ-
broblasts are incubated in standard culture medium containing 10%
(v / v) fetal calf serum, sulfhydryls are produced in culture medium,
achieving maximal levels within 6 h ( Fig. 2 ) [ 16 ]. Cysteine is rapidly
produced in the medium upon incubation with cells which is depen-
dent on cellular cystine uptake and the efﬂux of cysteine from cells.
Levels of cysteine after 6 h or later can reach around 20 μM in the
culture medium, a level almost equivalent to that measured in blood
[ 15 ]. Masked sulfhydryl residues in albumin are gradually reduced by
the sulfhydryl-disulﬁde exchange reaction with cysteine and reach a
similar level to cysteine within 48 h ( Fig. 2 ) [ 16 ]. Thus, ﬁbroblasts are
able to produce cysteine from cystine and sulfhydryl residues in albu-
min in the culture medium [ 16 ]. Fibroblasts are often used as feeder
layer cells to ensure survival and growth of cells deﬁcient in cystine
transporter activity ( Table 1 ). Cells expressing cystine transport ac-
tivity like ﬁbroblasts can release cysteine into the culture medium,
which in turn supports the proliferation of other cells which lack or
have low cystine transport activity ( Fig. 2 ). 
A recent review by Lewrenz et al. summarizes expression of system
x c − in vivo [ 31 ]. The expression of xCT was detected in brain including
meninges and some circumventricular organs [ 32 ] and spinal cord
[ 33 ], but not in lung, heart, liver and kidney [ 31 –33 ]. Mice lacking
xCT are healthy in appearance and fertile, although cystine and GSH
contents in plasma are lower in knockout compared to wild type mice
[ 34 ]. As expected, embryonic ﬁbroblasts derived from xCT deﬁcient
mice require 2ME for their survival and proliferation in in vitro [ 34 ]. 
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Table 1 
Mammalian cells used as feeder cells (A) and 2-mercaptoethanol dependent cells (B). 
A. Feeder cells used to maintain mammalian cells Feeder-dependent cells References 
Mouse macrophages Mouse spleen lymphocytes [ 1 ] 
Mouse thymus stromal cells Mouse T lymphocytes [ 2 ] 
Human skin ﬁbroblasts Human malignant lymphoma cells [ 3 ] 
Human epithelial cells Human malignant lymphoma cells [ 3 ] 
Mouse embryonic Fibroblasts Mouse embryonal carcinoma cells [ 5 ] 
Mouse ﬁbroblasts Mouse pluripotent haemopoietic stem cells [ 6 ] 
Human mesenchymal stromal cells Human haematopoietic stem cells [ 7 ] 
Mouse embryonic ﬁbroblasts Human embryonic stem cells, iPS cells Cited in reviews [ 8 –11 ] 
Human ﬁbroblasts Human embryonic stem cells Cited in reviews [ 8 –11 ] 
B. 2-mercaptoethanol-dependent cells References 
Mouse spleen lymphocytes [1] 
Mouse lymphoma L1210 [4] 
Human embryonic stem cells, iPS cells Cited in reviews [ 8 –11 ] 
Fig. 1. Role of cystine transport in the maintenance of intracellular cysteine and GSH levels. Cysteine (CySH) is rapidly air-oxidized to cystine (CyS–SCy) in culture media catalyzed 
by reactions with transition metals. The speciﬁc cystine / glutamate Na + -independent transport system x c − transports one cystine into cells in exchange for export of one glutamate 
molecule [ 14 , 23 ]. The cystine transporter is composed of a heterodimer, 4F2hc and xCT [ 28 ]. Induction of xCT expression by oxidative stress is regulated by Nrf2 while 4Fhc is 
constitutively expressed. Cystine is reduced to cysteine in cells, but efﬂuxes from cells via neutral amino acid transporters including system L. A high concentration of glutamine in 
culture media contributes to the maintenance of high concentrations of intracellular glutamate, which facilitate efﬁcient import of cystine via system x c − . GSH has a short half-life, 
since it is rapidly exported through transporters such as multidrug resistance-associated proteins (MRPs) [ 29 ]. GSH is cleaved into cysteinylglycine and amino acids by plasma 
membrane-bound enzymes [ 29 ]. 
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iffects of cysteine stabilization and 2-mercaptoethanol on 
roliferation of lymphocytes 
Although cystine transport activity is important for growth and 
urvival of cells in culture, some cells such as murine lymphocytes 
nd lymphoid cells are deﬁcient in cystine transport activity [ 13 , 18 ]. 
hese cells cannot survive and proliferate in standard deﬁned culture 
edia, as they depend on the supply of cysteine which is unstable 
n culture medium. Culture media contain trace amounts of heavy 
etals that catalyze oxidation of cysteine to cystine in the presence 
f oxygen. Copper ions are one of the metal ions catalyzing oxida- 
ion of cysteine. Supplementing a nontoxic copper-speciﬁc chelat- 
ng agent, 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline disulfonic acid (bathocuproine sulfonate, BCS) to culture medium (e.g. RPMI 
1640) inhibits oxidation of cysteine and enhances proliferation of 
murine lymphoid L1210 cells, which lack cystine transport activity 
[ 13 ]. Notably, following addition of cysteine at a concentration of 
50 μM to fresh culture medium in the absence of cells, roughly 90% 
of cysteine is oxidized within 2 h. However, in the presence of 10 μM 
BCS, only about 20%, 50%, and 75% cysteine is oxidized after 2, 8 and 
24 h, respectively ( Fig. 3 ). When 50 μM cysteine is supplemented at 
24 h intervals in the presence of 10 μM BCS, L1210 cells continuously 
proliferate at maximal rates ( Fig. 3 ) [ 13 ]. 
The maintenance of GSH in murine spleen lymphocytes also 
largely dependent on cysteine [ 18 ]. Stimulation of lymphocytes either 
with lipopolysaccharide (LPS) or Concanavalin A markedly increases 
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Fig. 2. Fibroblasts serve as feeder cells by providing cysteine to co-cultured cells deﬁcient in cystine transport activity. When human diploid ﬁbroblasts are cultured in fresh 
medium containing 10% (v / v) fetal bovine serum, which has been oxidized during storage, they rapidly produce sulfhydryls in the medium [ 16 ]. These cells take up cystine via 
system x c − and reduce it to cysteine intracellularly. Cellular cysteine in turn can efﬂux from cells and accumulate in the medium. Cysteine gradually unmasks cysteine residues in 
albumin, producing protein sulfhydryls via an SH / S −S exchange reaction. As ﬁbroblasts release cysteine into the culture medium, these cells can be used as feeder cells to provide 
cysteine for other cells lacking cystine transporter activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 cysteine transport activity. The uptake of cysteine is mainly mediated
through system A and ASC. In contrast, both LPS-stimulated and fresh
resting lymphocytes have extremely low cystine transport activities,
and thus depend on extracellular cysteine for maintenance of intra-
cellular GSH levels [ 18 ]. In the absence of cysteine in culture medium,
intracellular GSH decreases by roughly one-third within 8 h. How-
ever, addition of 50 μM cysteine every 8 h in the presence of 20 μM
BCS maintains cellular GSH levels in the activated lymphocytes [ 18 ]. 
A small thiol compound 2ME has routinely been supplemented in
culture medium for murine lymphocytes and lymphoid cells ( Table 1 ),
which lack cystine transport activity [ 18 ]. When 2ME is supplemented
to culture medium at 10–50 μM, these cells survive and prolifer-
ate in a standard cystine containing medium, noting that RPMI1640
medium contains 0.23 mM cystine. The major role of 2ME is to main-
tain intracellular cysteine and GSH levels by facilitating cystine and
cysteine transport [ 35 ]. A molecule of 2ME reacts with a cystine pro-
ducing cysteine and a mixed-disulﬁde of 2ME via an SH and S −S
exchange reaction in culture medium ( Fig. 3 ). Both cysteine and the
mixed disulﬁde can be transported into cells via membrane trans-
porters for neutral amino acids. The mixed disulﬁde is then reduced
in cells generating cysteine and 2ME, with the latter efﬂuxing from
 cells and reacting again with cystine. Due to this catalytic action of
2ME, cells can maintain cellular cysteine and GSH levels during cul-
ture in the absence of cystine transport activity [ 35 ] ( Fig. 3 ). 
Although expression of system x c − is low in murine lymphocytes, it
can be expressed in splenic T lymphocytes isolated from mice 10 days
after thermal injury [ 36 ]. Thermal injury induces oxidative stress,
decreases GSH and protein levels, leading to enhanced expression of
xCT. The acquired cystine transport activity is sufﬁcient to support
cell proliferation without 2ME in culture medium [ 36 ]. 
Upregulation of cystine transport activity by Nrf2 and ATF4 
Notably, cystine transport activity is upregulated under oxidative
stress [ 37 –40 ]. Fig. 4 shows the effect of electrophilic agents such
as diethylmaleate on the upregulation of cellular cystine transport
activity and GSH levels [ 37 ]. Diethylmaleate is known as a GSH de-
pleting agent, and addition of this agent at 1 mM to culture media of
human ﬁbroblasts causes a rapid decline in cellular GSH to 20% within
3–4 h and to almost negligible levels within 12 h leading to cell death
[ 38 ]. However, diethylmaleate at 0.1 mM induces more than a 2-fold
increase in cellular GSH over 15 h, noting however that there is a
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Fig. 3. Cells deﬁcient in cystine transport activity depend on cysteine for their survival and proliferation. Some cells such as murine lymphocytes and lymphoma L1210 cells do 
not express cystine transporters and largely depend on supply of extracellular cysteine for their survival. Supplemented cysteine is rapidly auto-oxidized in culture media in cell 
free conditions, but the presence of the copper chelator bathocuproine sulfonate (BCS) signiﬁcantly prolongs the half-life of cysteine from about 30 min to 8 h. Addition of 50 μM 
cysteine to culture media every 24 h in the presence of 10 μM BCS supports continuous growth of L1210 murine lymphoma cells in RPMI1640 medium containing 10% (v / v) fetal 
calf serum [ 13 ]. Another method is to supplement a small thiol compound 2-mercaptoethanol (2ME) to the culture medium, which catalytically facilitates cysteine transport [ 19 ]. 
The mixed disulﬁde of cysteine and 2ME formed in the medium is stable and can be taken up by the cells via neutral amino acid transporters. It is reduced within the cells to 
cysteine and 2ME, with 2ME released back into medium. Due to its catalytic action, 2ME is routinely used at 20–50 μM concentrations for prolonged support of cell survival and 
growth of murine lymphocytes. 
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aransient decrease in GSH over the ﬁrst 3 h [ 38 ]. The increase in GSH 
s accompanied by a marked increase in cystine transport activity, re- 
ulting from the activation of Nrf2 and upregulation of xCT expression 
 28 ] ( Fig. 4 ). Thus, a low dose of diethylmaleate can induce cellular 
esponses that enable cells to become more resistant to electrophilic 
gents and oxidative stress. 
Notably xCT expression is also upregulated in NIH3T3 cells follow- 
ng removal of amino acids including cystine in culture media [ 41 ]. In 
ddition to Nrf2, the transcription factor ATF4 activates xCT gene ex- 
ression through a cis -element termed amino acid response element 
 41 ]. An oxidation product of γ-tocopherol, γ-tocopheryl quinone, 
eacts with nucleophiles inducing toxicity and activates ATF4 leading 
pregulation of xCT expression [ 42 ]. 
rf2-mediated regulation of redox balance in cultured cells 
The transcription factor Nrf2 regulates expression of many genes 
ia its interaction with ARE / EpRE elements in their regulatory re- 
ion [ 43 ]. Nrf2 target genes include a group of phase II detoxiﬁca- 
ion enzymes including glutathione- S -transferase [ 43 ]. In addition to 
CT, Nrf2 also regulates expression of other key proteins important 
or defense against oxidative stress [ 20 ]. Heme oxygenase 1 (HO- 
), peroxiredoxin 1 (Prx1) and sequestosome1 / p62 ( Fig. 5 ) are ma- 
or proteins induced following Nrf2 activation in murine peritoneal 
acrophages [ 20 ] and aortic smooth muscle cells [ 21 ]. HO-1 and Prx1 
re well known endogenous antioxidants, and enhanced expression 
f these proteins and increases GSH via xCT up regulation ensure pro- 
ection of cells against oxidative damage. Sequestosome1 / p62 is a 
odulator of cell signaling with multifunctional activities including 
nti-inﬂammatory functions [ 44 , 45 ]. Various electrophilic agents such as diethylmaleate activate Nrf2 
through direct interaction with the reactive sulfhydryls in the cy- 
tosolic sensor protein Keap1 [ 46 ]. Oxidized lipid metabolites, con- 
tinuously produced in cells and tissues, contain intrinsic activators of 
Nrf2 such as 4-hydroxynonenal (4HNE), and thus function as an alarm 
signal for oxidative stress [ 21 , 47 ]. Circulating oxidized LDL (oxLDL) is 
associated with clinical manifestations of atherosclerosis. Continual 
oxidation of LDL occurs in vivo, and the products are removed by cells 
expressing scavenger receptors for oxLDL [ 48 , 49 ]. Exposure of oxLDL 
induces cellular responses such as upregulation of cystine transport 
activity and GSH synthesis in mouse peritoneal macrophages [ 50 ] 
and human arterial smooth muscle cells [ 51 ]. Upregulation of GSH 
by oxLDL is accompanied by an increase in glutamate-cysteine ligase 
in bovine aortic endothelial cells [ 52 ]. GSH upregulation by oxLDL is 
mediated via AREs / EpREs [ 53 ], and the transcription factor Nrf2 plays 
key role in oxLDL induced cellular responses [ 21 ]. We examined ef- 
fects of 4HNE, lipid hydroperoxides, oxysterols and other aldehydes 
contained in oxidized LDL on Nrf2 activation, and found that 4HNE 
was the most effective activator of Nrf2 [ 21 ]. The estimated amount 
of 4HNE in oxLDL was sufﬁcient to cause Nrf2 activation [ 21 ]. 
A scavenger receptor CD36, which is expressed in macrophages 
and platelets, is a major receptor for oxLDL. Notably, oxLDL upreg- 
ulates CD36 expression in macrophages forming a positive feedback 
to facilitate removal of toxic oxLDL from the microenvironment. In- 
duction of CD36 expression by oxidative stress largely depends on 
Nrf2 [ 21 , 54 ]. However, it should be noted that feeding a high fat 
diet in the absence of ApoE, which facilitates HDL-mediated choles- 
terol efﬂux from macrophages, results in enhanced atherosclerotic le- 
sion formation in wild type compared to Nrf2 deﬁcient mice [ 55 , 56 ]. 
These results highlight that the Nrf2-CD36 pathway could exacerbate 
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Fig. 4. Electrophilic agents and amino acid starvation up regulate xCT, resulting in increases in intracellular GSH. Diethylmaleate (DEM) is an electrophilic agent reactive with 
GSH and depletes GSH in human ﬁbroblasts when added at 1 mM to culture media. However, when supplemented at 0.1 mM, it increases cellular GSH more than 2 fold within 
15 h, preceded by an initial transient decrease over the ﬁrst 3 h. DEM activates Nrf2 and upregulates expression of xCT, resulting in an increase in cystine uptake and cellular GSH 
[ 20 , 28 , 38 ]. Amino acid starvation activates transcription factor ATF4 leading upregulation of xCT expression [ 41 ]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 atherosclerosis under conditions of elevated oxLDL levels. 
A small lipid oxidation metabolite 4HNE is a membrane perme-
able activator of Nrf2 and upregulates expression of CD36 and other
gene products in murine macrophages [ 21 ]. 4HNE also activates Nrf2
in vascular smooth muscle cells but CD36 is not expressed in murine
smooth muscle cells. However, there are studies reporting CD36 ex-
pression in human vascular smooth muscle cells [ 57 ]. As oxLDL does
not efﬁciently activate Nrf2 in murine vascular smooth muscle cells,
incorporation of oxLDL into cells may necessary for Nrf2 activation
[ 21 ]. In this context, upregulation of GSH is important, as 4HNE is
conjugated with GSH by glutathione- S -transferase and subsequently
reduced by aldo-keto reductases [ 58 ]. 
Importance of redox balance in stem cell culture 
Culturing stem cells commonly requires feeder cells to maintain
an undifferentiated state without losing pluripotency in culture [ 7 –
11 ]. Fibroblasts are usually used as feeder cells for ES cells and iPS cells
[ 7 –11 ] ( Table1 ). Mesenchymal stromal cells are also used for main-
tenance of hematopoietic stem cells in vitro [ 7 , 59 ]. A key function of
feeder cells is to stably provide cysteine for stem cell survival ( Fig.
2 ) and, in addition to other secreted factors, extracellular matrix and
cellular contacts for proliferating the stem cells. The requirement of
feeder cells or 2ME dependency of mammalian stem cells and humaniPS cells [ 7 –11 ] suggests they express low cystine transport activity
similar to mouse lymphocytes and lymphoid cells. 
Feeder-free stem cell culture has been developed in order to avoid
unfavorable effects such as contamination of pathogens from feeder
cells [ 8 –11 ]. Interestingly, feeder-free media generally contain 2ME
at a concentration similar to that used for murine lymphocyte in cul-
ture [ 8 –11 , 60 ]. As described previously, 2ME can improve the redox
balance by enhancing cysteine uptake to maintain cellular GSH levels
( Fig. 3 ). Another method to maintain stem cells without feeder cells
is to use ﬁbroblast conditioned medium. In an open protocol pro-
vided by NIH [ 60 ], fresh medium was ﬁrst applied to a monolayer of
ﬁbroblasts for one day, and stem cells were then incubated with this
conditioned medium and seeded on Matrigel, which provides ma-
trix for cell attachment. The conditioned medium is replaced daily to
support continuous growth of stem cell colonies [ 60 ]. It has been re-
ported that air-oxidized medium can be reduced to produce cysteine
and albumin sulfhydryls following incubation with ﬁbroblasts ( Fig. 2 )
[ 16 ]. Interestingly, cysteine either present in the medium or supple-
mented to the medium is relatively stable, which may partly be due
to stability of protein thiols and reduced free transition metal ions
after incubation with the ﬁbroblasts. In this context, supplementing
conditioned media daily mimics a culture condition with repeated
cysteine supply in the presence of a copper ion chelator [ 13 ] ( Fig. 3 ). 
Basic ﬁbroblast growth factor (FGF-2) is commonly included as
792 T. Ishii, Giovanni E. Mann / Redox Biology 2 (2014) 786–794 
Fig. 5. Activation of transcription factor Nrf2 by oxidized LDL and 4-hydroxynonenal in peritoneal macrophages. Both oxLDL and membrane permeable lipid metabolite 4HNE 
function as alarm signals for oxidative stress and activate Nrf2 leading to the upregulation of different endogenous antioxidants and CD36 expression in macrophages [ 21 ]. CD36 
is a scavenger receptor which mediates roughly half of oxLDL uptake by macrophages, thereby contributing to the removal of toxic oxLDL from the micro-environment [ 21 ]. As 
oxLDL upregulates its receptor CD36 mainly via Nrf2 activation, the reaction provides a positive feedback loop. Exposure of murine peritoneal macrophages to elevated oxLDL 
concentrations leads to an upregulation of CD36 and accumulation of oil droplets in the cytoplasm [ 21 ]. In this context, Nrf2 facilitates foam cell formation under enhanced oxLDL 
loading [ 55 , 56 ]. Nrf2 activation in macrophages also upregulates antioxidant enzymes such as heme oxygenase-1 (HO-1) and peroxiredoxin 1 (Prx1) and the subunit of the x c −
transport system xCT to protect the cells from oxidative damage. Sequestosome1 / p62 is known to modulate receptor mediated signaling and suppresses inﬂammation, however 
its antioxidant function remains to be deﬁned [ 45 , 54 ]. 
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  supplement in culture media for various stem cells and iPS cells 
 8 –11 ]. FGF-2 activates cellular signaling through FGF receptors in 
ooperation with heparin to induce its pleiotropic effects including 
ngiogenic and neurogenic effects [ 61 –63 ]. Notably, FGF-2 activates 
he stress related transcription factor ATF4 in vascular smooth mus- 
le cells [ 64 ] and osteoblasts [ 65 ]. FGF-2 upregulated GSH synthesis 
n glial [ 66 ] and Sertoli cells [ 67 ] and cystine / glutamate transport 
system x c − ) in astrocytes [ 68 ]. These results suggest that cystine 
ransport activity may be upregulated in the presence of FGF-2 in 
tem cells or differentiating cells via FGF-2 / ATF4 signaling, leading 
o improved survival and growth, however, to our knowledge this 
ypothesis remains to be investigated. 
ummary 
Understanding the mechanisms regulating redox balance in cells 
ultured in vitro is important for the design of cell type speciﬁc cul- 
ure conditions. Maintenance of cellular GSH levels during culture is 
 key redox indicator for protection of DNA against oxidative damage. 
ost mammalian cells, excluding hepatocytes, which can synthesize 
ysteine from methionine, depend largely on supply of cysteine or 
ystine for GSH synthesis, as glycine and glutamate are usually main- 
ained at higher levels in cells cultured in conventional culture media. 
Improving the culture conditions for various stem cells and iPS will 
e particularly important for clinical applications. Further research is required to establish feeder-free and serum-free deﬁned culture con- 
ditions for the maintenance of stem and iPS cells in healthy conditions 
and for inducing their differentiation into desired cell types. Stem 
cell biology will be signiﬁcantly improved by designing redox bal- 
ance based culture conditions which will allow different stem cells to 
maintain proliferation without losing pluripotency, to enhance their 
differentiation and to select desired differentiated cells from others. 
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